Research indicated that the P/C ratio offers a quicker and more effective method for identifying significant proteinuria in the context of preeclampsia risk stratification. Preeclampsia remains a major cause of maternal and neonatal morbidity...
Research indicated that the P/C ratio offers a quicker and more effective method for identifying significant proteinuria in the context of preeclampsia risk stratification. Preeclampsia remains a major cause of maternal and neonatal morbidity...
The following is a summary of "Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer treatment," published in the April 2025 issue of Cancer Nanotechnology by Moghaddam et al. Breast cancer continues to be one of the most commonly...
Birth weight (BW) is a key indicator of a newborn's health, survival, and development. It is associated with the risk of childhood mortality and is also related to health, physical growth, emotional well-being, and academic success throughout both childhood and...
Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), has demonstrated promising outcomes in treating HER2-negative early-stage breast cancer with BRCA mutations. However, a comprehensive evaluation of its cost-effectiveness in the context of the United...
Endoplasmic reticulum (ER) stress is increasingly recognized as a driver of cancer progression; however, the precise molecular mechanisms by which ER stress facilitates tumor metastasis remain incompletely understood. In this study, we demonstrate that ER...
THURSDAY, April 10, 2025 (HealthDay News) -- In a special article published online March 19 in the Journal of Clinical Oncology, the American Society of Clinical Oncology presents updated recommendations for fertility preservation (FP) in people with cancer.H....
The following is a summary of "Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer treatment," published in the April 2025 issue of Cancer Nanotechnology by Moghaddam et al. Breast cancer continues to be one of the most commonly...
Birth weight (BW) is a key indicator of a newborn's health, survival, and development. It is associated with the risk of childhood mortality and is also related to health, physical growth, emotional well-being, and academic success throughout both childhood and...
Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), has demonstrated promising outcomes in treating HER2-negative early-stage breast cancer with BRCA mutations. However, a comprehensive evaluation of its cost-effectiveness in the context of the United...
Endoplasmic reticulum (ER) stress is increasingly recognized as a driver of cancer progression; however, the precise molecular mechanisms by which ER stress facilitates tumor metastasis remain incompletely understood. In this study, we demonstrate that ER...
THURSDAY, April 10, 2025 (HealthDay News) -- In a special article published online March 19 in the Journal of Clinical Oncology, the American Society of Clinical Oncology presents updated recommendations for fertility preservation (FP) in people with cancer.H....
The latest news from SABCS 2024 focused on breast cancer including abstracts, features, and helpful conference information.
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on preeclampsia from different vantage points.
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on breast cancer from different vantage points.
As new physicians match, the system they enter needs repair.
This medical fiction takes place in a chaotic ED where a nurse is assigned an impossible case. As the patient defies all odds, a shocking crime unfolds.
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve clinical outcomes and QOL.
This course discusses the mechanism behind pain that occurs months to years after the completion of breast cancer treatment as well as the effect of disease progression on pain.
Cannabis use is rising for medical benefits, but physicians call for more research and clearer regulations due to potential risks.
The healthcare industry has undergone a number of significant alterations that have added to the already challenging task of revenue-cycle management.
The National Resident Matching Program (NRMP) shared results from the 2025 Main Residency Match, the largest in its history.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.